Matthew Osborne

Associate Vice President Network Technical Services/Manufacturing Sciences at Eli Lilly, Ireland

Speaker

Matt is currently an Associate Vice President (Technical), for manufacturing Sciences, Biotech, Eli Lilly. In this role Matt has responsibilities for biotech manufacturing technical strategy for Lilly’s cell culture platform. More recently, Matt has been involved in developing Lilly’s strategy for manufacturing of ATMP/CGT therapeutics, including design of Lilly’s gene therapy manufacturing facility in Lebanon, Indiana and partnering with R&D on commercialisation of the gene therapy product portfolio.

Matt has approximately 25 years experience in process development, technology transfer, process validation, registration and manufacturing support for mammalian and microbial expression systems. Prior to Lilly, Matt held roles at Cambridge Antibody Technology (Astra Zeneca), Pfizer and UCB Celltech. He joined Lilly in 2008 as Lilly began to establish the biotech product portfolio and commercial manufacturing footprint. He has been heavily involved in manufacturing facility start up and the commercialisation of many of Lilly’s cell culture-based products.

Matt received his BSc in Biotechnology from De Montfort University, Leicester, UK and a Ph.D. in Biochemical Engineering from University College London, London, UK.